| Sorafenib With TACE to Treat Hepatocellular Carcinoma (NCT00478374) | University of Bern | 2007-05-01 |
| Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin (NCT01322386) | Stanford University | 2007-05-01 |
| Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors (NCT00606125) | Bayer | 2007-05-01 |
| Aricept to Improve Functional Tasks in Vascular Dementia (NCT00457769) | Kessler Foundation | 2007-05-01 |
| Corneal Endothelial Cell Density Changes In Healthy Subjects, When Administered ISV-403 for 5 Days (NCT01120418) | Bausch & Lomb Incorporated | 2007-05-01 |
| Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma (NCT00399113) | Pain Therapeutics | 2007-05-01 |
| Essential Amino Acids Supplementation and Muscle Protein Synthesis (NCT01366924) | United States Army Research Institute of Environmental Medicine | 2007-05-01 |
| A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NCT00452127) | Genentech, Inc. | 2007-05-01 |
| Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours (NCT00809133) | Boehringer Ingelheim | 2007-05-01 |
| Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder (NCT00572377) | Cedars-Sinai Medical Center | 2007-05-01 |
| A Study of Enzastaurin in Patients With Leukemia (NCT00452257) | Eli Lilly and Company | 2007-05-01 |
| Study of Cobimetinib in Participants With Solid Tumors (NCT00467779) | Genentech, Inc. | 2007-05-01 |
| A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia (NCT00482703) | Bristol-Myers Squibb | 2007-05-01 |
| "How do Contrast Medias in Bone Cement Affect DXA Measurements After THR" (NCT00473421) | Ullevaal University Hospital | 2007-05-01 |
| A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients (NCT00503984) | University of Miami | 2007-05-01 |
| Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults (NCT00623753) | St. Jude Children's Research Hospital | 2007-05-01 |
| Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (NCT00464113) | Exelixis | 2007-05-01 |
| Preventing Child Maltreatment Through A Cellular-Phone Technology-Based Parenting Program (NCT01294475) | Centers for Disease Control and Prevention | 2007-05-01 |
| Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) (NCT00478465) | Stanford University | 2007-05-01 |
| Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453 (NCT02845037) | Bial - Portela C S.A. | 2007-05-01 |
| Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) (NCT00652431) | Organon and Co | 2007-05-01 |
| Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies (NCT00481871) | Acrotech Biopharma Inc. | 2007-05-01 |
| Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults (NCT00473967) | Albert B. Sabin Vaccine Institute | 2007-05-01 |
| The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies (NCT00468260) | Novartis Pharmaceuticals | 2007-05-01 |
| Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia (NCT00493545) | Nventa Biopharmaceuticals Corporation | 2007-05-01 |
| Trunk Muscle Training and Neuromuscular Electrical Stimulation to Improve Function in Older Adults With Chronic Low Back Pain (NCT01632618) | University of Delaware | 2007-05-01 |
| Mechanisms of Neural Mobilization in the Treatment of Chronic Pain (NCT00929123) | University of Florida | 2007-05-01 |
| Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male Volunteers (NCT02261077) | Boehringer Ingelheim | 2007-05-01 |
| The ATLANTA First in Man Study of the Catania Stent (NCT00799032) | CeloNova BioSciences, Inc. | 2007-05-01 |
| A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (NCT00458159) | Celgene | 2007-05-01 |
| Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects (NCT00470925) | Institute for Neurodegenerative Disorders | 2007-05-01 |
| Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation (NCT00817752) | National University of Natural Medicine | 2007-05-01 |
| Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo (NCT00689858) | SK Chemicals Co., Ltd. | 2007-05-01 |
| Viagra in the Treatment of Primary Dysmenorrhea (NCT00123162) | Milton S. Hershey Medical Center | 2007-05-01 |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma (NCT00562068) | Cancer Research UK | 2007-05-01 |
| A Phase I Extension Trial of Repeated Infusions of ISF35 (NCT00783588) | Memgen, LLC | 2007-05-01 |
| Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro) (NCT00472927) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-05-01 |
| A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas (NCT00532948) | Hoffmann-La Roche | 2007-05-01 |
| Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin (NCT00481936) | Sesen Bio, Inc. | 2007-05-01 |
| Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]) (NCT00431808) | African Malaria Network Trust | 2007-05-01 |
| Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS (NCT00464321) | Genzyme, a Sanofi Company | 2007-05-01 |
| Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma (NCT00458731) | National Cancer Institute (NCI) | 2007-05-01 |
| Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study (NCT00517998) | Aeris Therapeutics | 2007-05-01 |
| A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication (NCT00482963) | University of Colorado, Denver | 2007-05-01 |
| Local Anesthetics New Formulations: From Development to Clinical Tests (NCT01032798) | University of Campinas, Brazil | 2007-05-01 |
| Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant (NCT00569283) | Asan Medical Center | 2007-05-01 |
| Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509) (NCT00469053) | Grünenthal GmbH | 2007-05-01 |
| Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg. (NCT00551473) | GlaxoSmithKline | 2007-05-01 |
| Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases (NCT00376519) | Masonic Cancer Center, University of Minnesota | 2007-05-01 |
| The Anti-allergic Effects of Specific Probiotics (NCT00480129) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2007-05-01 |
| Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device (NCT00503919) | M.D. Anderson Cancer Center | 2007-05-01 |
| A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT (NCT00477542) | Indiana University | 2007-05-01 |
| Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) (NCT01025596) | Cytheris SA | 2007-05-01 |
| Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate (NCT00489840) | Manhattan Eye, Ear & Throat Hospital | 2007-05-01 |
| Walking Study for Stroke Rehabilitation (NCT00428480) | University of California, Los Angeles | 2007-05-01 |
| Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma (NCT00538005) | San Diego Pacific Oncology & Hematology Associates | 2007-05-01 |
| A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer (NCT00482014) | Eli Lilly and Company | 2007-05-01 |
| A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma (NCT00717184) | National University Hospital, Singapore | 2007-05-01 |
| Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1) (NCT00901849) | Roger Packer | 2007-05-01 |
| Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT00633724) | Fukushima Medical University | 2007-05-01 |
| Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates (NCT00599053) | University of Alabama at Birmingham | 2007-05-01 |
| Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (NCT01300793) | University of California, San Francisco | 2007-05-01 |
| Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients (NCT00472082) | Emory University | 2007-05-01 |
| A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children (NCT00468819) | Bayer | 2007-05-01 |
| Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL (NCT00477945) | Indiana University | 2007-05-01 |
| A Study of Radiation With Sorafenib in Advanced Cancer (NCT00610246) | University Health Network, Toronto | 2007-05-01 |
| Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection (NCT00485134) | U.S. Army Medical Research and Development Command | 2007-05-01 |
| Antidepressant Effects of NR2B in Major Depression (NCT00472576) | National Institute of Mental Health (NIMH) | 2007-05-01 |
| An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors (NCT00514267) | Astellas Pharma Inc | 2007-05-01 |
| A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822) (NCT00711607) | Organon and Co | 2007-05-01 |
| Study of Pharmacokinetics and Pharmacodynamics of Artesunate in Pregnant Women in the Democratic Republic of Congo (NCT00538382) | NICHD Global Network for Women's and Children's Health | 2007-05-01 |
| Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT00473928) | Potentia Pharmaceuticals, Inc. | 2007-05-01 |
| TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study (NCT00478517) | Hospices Civils de Lyon | 2007-05-01 |
| Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement (NCT00454298) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-05-01 |
| Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies (NCT00473551) | M.D. Anderson Cancer Center | 2007-05-01 |
| A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer (NCT00452413) | Eli Lilly and Company | 2007-05-01 |
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (NCT00470977) | Manhattan Eye, Ear & Throat Hospital | 2007-05-01 |
| Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors (NCT00636545) | Genta Incorporated | 2007-05-01 |
| Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies (NCT00894894) | Astex Pharmaceuticals, Inc. | 2007-05-01 |
| Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine (NCT00473135) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-05-01 |
| Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours (NCT00475956) | AstraZeneca | 2007-05-01 |
| Pharmacokinetic Investigation of UDCA in Bile and Serum (NCT00529009) | Dr. Falk Pharma GmbH | 2007-05-01 |
| Safety Study of IL-7 in HIV-infected Patients (Inspire) (NCT00477321) | Cytheris SA | 2007-05-01 |
| Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy (NCT00503568) | University of Miami | 2007-05-01 |
| Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients (NCT00479219) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-05-01 |
| Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma (NCT00483262) | Dana-Farber Cancer Institute | 2007-05-01 |
| Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies (NCT00496860) | Altor BioScience | 2007-05-01 |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT00478634) | Novartis Pharmaceuticals | 2007-05-01 |
| Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib (NCT00473486) | University Hospital Muenster | 2007-05-01 |
| Exercise Induced Bronchoconstriction (0476-359) (NCT00664937) | Organon and Co | 2007-05-01 |
| Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941 (NCT01288898) | Astellas Pharma Inc | 2007-05-01 |
| A Study of MK0657 in Parkinson's Disease Patients (0657-006) (NCT00505843) | Merck Sharp & Dohme LLC | 2007-05-01 |
| An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma. (NCT00420056) | Pfizer | 2007-05-01 |
| A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis (NCT00455208) | Cura Biotech LLC | 2007-05-01 |
| Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers (NCT00473720) | Yale University | 2007-05-01 |
| A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers (NCT00463918) | Pfizer | 2007-05-01 |
| A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors (NCT00487058) | Novartis | 2007-05-01 |
| Internal Fixation of Lateral Humeral Condyle Fractures With Absorbable Screws in Children (NCT02733666) | Children's Hospital of Chongqing Medical University | 2007-05-01 |
| Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC (NCT00522249) | The Methodist Hospital Research Institute | 2007-05-01 |
| Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate (NCT02288312) | Bial - Portela C S.A. | 2007-05-01 |